IL17A and endometriosis: Recent evidence has elucidated a dysregulated IL-23/Th17 axis in endometriosis, demonstrating that IL-23 drives local immune dysfunction through promotion of Th17 differentiation and IL-17 production, thereby contributing to chronic inflammation and lesion persistence (95).